PMC:7243768 / 6462-6728 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"221","span":{"begin":259,"end":262},"obj":"Gene"},{"id":"229","span":{"begin":217,"end":228},"obj":"Chemical"},{"id":"257","span":{"begin":114,"end":126},"obj":"Disease"}],"attributes":[{"id":"A221","pred":"tao:has_database_id","subj":"221","obj":"Gene:1636"},{"id":"A229","pred":"tao:has_database_id","subj":"229","obj":"MESH:D000450"},{"id":"A257","pred":"tao:has_database_id","subj":"257","obj":"MESH:D006973"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" receptors due to which there is an increase in blood pressure [17,18]. Therefore, ACEi and ARBs are used as anti-hypertensive treatment options [18] (Fig. 1 ).\nFig. 1 The abnormal activation of the Renin-Angiotensin-Aldosterone system (RAAS) pathway via the ACE-Ang"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T54","span":{"begin":48,"end":53},"obj":"Body_part"}],"attributes":[{"id":"A54","pred":"fma_id","subj":"T54","obj":"http://purl.org/sig/ont/fma/fma9670"}],"text":" receptors due to which there is an increase in blood pressure [17,18]. Therefore, ACEi and ARBs are used as anti-hypertensive treatment options [18] (Fig. 1 ).\nFig. 1 The abnormal activation of the Renin-Angiotensin-Aldosterone system (RAAS) pathway via the ACE-Ang"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T20","span":{"begin":48,"end":53},"obj":"Body_part"}],"attributes":[{"id":"A20","pred":"uberon_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":" receptors due to which there is an increase in blood pressure [17,18]. Therefore, ACEi and ARBs are used as anti-hypertensive treatment options [18] (Fig. 1 ).\nFig. 1 The abnormal activation of the Renin-Angiotensin-Aldosterone system (RAAS) pathway via the ACE-Ang"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T74","span":{"begin":36,"end":62},"obj":"Disease"}],"attributes":[{"id":"A74","pred":"mondo_id","subj":"T74","obj":"http://purl.obolibrary.org/obo/MONDO_0005044"}],"text":" receptors due to which there is an increase in blood pressure [17,18]. Therefore, ACEi and ARBs are used as anti-hypertensive treatment options [18] (Fig. 1 ).\nFig. 1 The abnormal activation of the Renin-Angiotensin-Aldosterone system (RAAS) pathway via the ACE-Ang"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T102","span":{"begin":48,"end":53},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T103","span":{"begin":48,"end":53},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T104","span":{"begin":146,"end":148},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T105","span":{"begin":181,"end":191},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":" receptors due to which there is an increase in blood pressure [17,18]. Therefore, ACEi and ARBs are used as anti-hypertensive treatment options [18] (Fig. 1 ).\nFig. 1 The abnormal activation of the Renin-Angiotensin-Aldosterone system (RAAS) pathway via the ACE-Ang"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T45","span":{"begin":83,"end":87},"obj":"Chemical"},{"id":"T46","span":{"begin":205,"end":216},"obj":"Chemical"},{"id":"T47","span":{"begin":217,"end":228},"obj":"Chemical"}],"attributes":[{"id":"A45","pred":"chebi_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/CHEBI_35457"},{"id":"A46","pred":"chebi_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/CHEBI_2719"},{"id":"A47","pred":"chebi_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/CHEBI_27584"}],"text":" receptors due to which there is an increase in blood pressure [17,18]. Therefore, ACEi and ARBs are used as anti-hypertensive treatment options [18] (Fig. 1 ).\nFig. 1 The abnormal activation of the Renin-Angiotensin-Aldosterone system (RAAS) pathway via the ACE-Ang"}

{"project":"LitCovid-sentences","denotations":[{"id":"T45","span":{"begin":72,"end":160},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" receptors due to which there is an increase in blood pressure [17,18]. Therefore, ACEi and ARBs are used as anti-hypertensive treatment options [18] (Fig. 1 ).\nFig. 1 The abnormal activation of the Renin-Angiotensin-Aldosterone system (RAAS) pathway via the ACE-Ang"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T32","span":{"begin":36,"end":62},"obj":"Phenotype"}],"attributes":[{"id":"A32","pred":"hp_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/HP_0032263"}],"text":" receptors due to which there is an increase in blood pressure [17,18]. Therefore, ACEi and ARBs are used as anti-hypertensive treatment options [18] (Fig. 1 ).\nFig. 1 The abnormal activation of the Renin-Angiotensin-Aldosterone system (RAAS) pathway via the ACE-Ang"}